Market Price

9.54 

0.10 1.1%

as of Aug 22 '19

52 Week Range:

8.54 14.96


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company operates in two segments, Clinical and Financial Solutions and Population Health. The Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related software, connectivity and coordinated care solutions, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. The Population Health segment offers health management, and financial management and patient engagement solutions to hospitals, health systems, accountable care organizations, and other care facilities. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name May '09 May '10 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 4.92
7.35
7.54
7.45
7.44
7.11
7.31
7.37
6.11
6.35
growth rate 22.2% 2.6% -1.2% -0.1% -4.4% 2.8% 0.8% -17.1% 3.9%
Earnings BIT 44.40
-2.96
117.48
-17.46
-148.35
-31.80
33.43
72.36
17.28
-19.72
growth rate -100.0% 100.0% -100.0% 0.0% 0.0% 100.0% 116.5% -76.1% -100.0%
Avg.PE 63.29
45.45
49.26
-2,069.60
-14.63
-14.63
-14.63
638.75
-13.00
887.27
growth rate -15.3% 8.4% -100.0% 0.0% 0.0% 0.0% 100.0% -100.0% 100.0%
ROA 2.73
6.14
-0.20
2.98
-0.05
-4.16
-2.59
-0.09
-0.79
-4.87
9.82
growth rate 124.9% -100.0% 100.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0%
ROE 3.72
8.34
-0.40
5.15
-0.08
-7.99
-5.11
-0.17
-1.94
-16.70
27.23
growth rate 124.2% -100.0% 100.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0%
ROIC 3.54
8.41
4.36
0.03
-4.97
-2.13
-5.67
-1.68
-4.95
16.79
growth rate 137.6% -28.0% -99.3% -100.0% 0.0% 0.0% 0.0% 0.0% 100.0%
Cur. Ratio 1.59
1.92
1.33
1.10
1.04
1.00
1.05
0.91
0.97
1.08
growth rate 20.8% -16.8% -17.3% -5.5% -3.9% 5.0% -13.3% 6.6% 11.3%
Quick Ratio 1.38
1.53
1.02
0.80
0.73
0.73
0.86
0.75
0.83
0.89
growth rate 10.9% -18.4% -21.6% -8.8% 0.0% 17.8% -12.8% 10.7% 7.2%
Leverage 1.36
1.36
1.70
1.86
1.99
1.95
1.91
3.11
3.77
2.05
growth rate 0.0% 11.8% 9.4% 7.0% -2.0% -2.1% 62.8% 21.2% -45.6%
Balance Sheet May '09 May '10 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 155.10
317.21
403.39
358.60
368.95
331.63
327.85
405.17
492.56
531.72
growth rate 43.0% 27.2% -11.1% 2.9% -10.1% -1.1% 23.6% 21.6% 8.0%
Acct.Payable 162.66
183.10
249.65
70.82
60.00
126.14
85.75
73.17
growth rate 12.6% 36.4% -71.6% -15.3% 110.2% -32.0% -14.7%
Cur.Assets 261.00
575.46
657.78
572.58
539.82
487.19
538.35
604.33
857.11
858.97
growth rate 48.5% 14.3% -13.0% -5.7% -9.8% 10.5% 12.3% 41.8% 0.2%
Total Assets 952.70
2,418.59
2,503.62
2,349.54
2,619.66
2,464.33
2,681.95
3,832.16
4,230.15
3,181.48
growth rate 59.3% 3.5% -6.2% 11.5% -5.9% 8.8% 42.9% 10.4% -24.8%
Cash 71.20
129.40
157.75
103.96
62.95
53.17
116.87
95.61
119.47
174.24
growth rate 34.8% 21.9% -34.1% -39.4% -15.5% 119.8% -18.2% 25.0% 45.9%
Inventory 2.60
3.82
0.00
0.00
growth rate 21.2% -100.0%
Cur.Liabilities 164.10
431.07
497.04
518.13
517.04
521.37
512.96
667.08
889.63
797.73
growth rate 62.1% 15.3% 4.2% -0.2% 0.8% -1.6% 30.1% 33.4% -10.3%
Liabilities 252.30
1,034.82
1,026.90
1,065.20
1,301.52
1,180.11
1,262.88
2,171.27
2,638.54
1,601.06
growth rate 102.5% -0.8% 3.7% 22.2% -9.3% 7.0% 71.9% 21.5% -39.3%
LT Debt 63.70
459.75
322.66
362.70
545.13
539.19
612.41
1,294.77
906.73
647.54
growth rate 168.7% -29.8% 12.4% 50.3% -1.1% 13.6% 111.4% -30.0% -28.6%
Equity 700.40
1,383.77
1,476.72
1,284.34
1,318.15
1,284.22
1,407.88
1,232.47
1,120.88
1,551.11
growth rate 40.6% 6.7% -13.0% 2.6% -2.6% 9.6% -12.5% -9.1% 38.4%
Common Shares 127.00
148.00
188.29
191.00
179.00
177.00
180.00
185.00
186.00
181.00
179.00
growth rate 16.5% 27.2% 1.4% -6.3% -1.1% 1.7% 2.8% 0.5% -2.7% -1.1%
Cash Flow Statement May '09 May '10 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures -6.50
61.49
44.31
80.17
74.13
26.44
18.32
32.11
38.76
31.31
growth rate 100.0% -28.0% 80.9% -7.5% -64.3% -30.7% 75.2% 20.7% -19.2%
Cash Dividends 0.00 0.00 0.00 0.00
growth rate
Cash From OA 36.10
75.78
268.75
222.67
80.99
103.50
211.58
269.00
279.42
67.89
growth rate 44.9% 254.7% -17.2% -63.6% 27.8% 104.4% 27.1% 3.9% -75.7%
FCF per Share 0.56
0.56
0.03
-0.04
0.63
0.81
0.37
0.12
growth rate 0.0% -94.6% -100.0% 100.0% 28.6% -54.3% -67.6%
Sale Purchase of Stock -16.34
-220.44
62.66
1.49
103.63
0.08
1.57
growth rate 0.0% 100.0% -97.6% 6,869.1% -99.9% 1,766.7%
FCF 17.00
105.00
14.29
163.00
100.00
-35.00
36.00
144.00
131.00
94.00
-77.00
growth rate 517.7% -86.4% 1,040.7% -38.7% -100.0% 100.0% 300.0% -9.0% -28.2% -100.0%
Income Statement May '09 May '10 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 548.40
613.31
1,444.08
1,446.33
1,373.06
1,377.87
1,386.39
1,386.07
1,497.71
1,749.96
growth rate 5.8% 135.5% 0.2% -5.1% 0.4% 0.6% 0.0% 8.1% 16.8%
Op.Income 45.90
5.89
73.61
-1.15
-104.03
-31.80
33.43
72.36
17.28
-19.72
growth rate -64.2% 1,149.7% -100.0% 0.0% 0.0% 100.0% 116.5% -76.1% -100.0%
IBT 44.40
-2.96
117.48
-17.46
-148.35
-68.12
0.57
31.56
-190.04
13.14
growth rate -100.0% 100.0% -100.0% 0.0% 0.0% 100.0% 5,436.8% -100.0% 100.0%
Net Income 26.00
-5.57
73.61
-1.15
-104.03
-66.45
-2.23
-25.65
-196.46
363.74
growth rate -100.0% 100.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0%
EPS 0.21
0.42
-0.03
0.39
-0.01
-0.59
-0.37
-0.01
-0.14
-1.09
2.04
growth rate 100.0% -100.0% 100.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0%
Gross Profit 292.20
298.17
665.57
606.54
534.46
632.20
662.55
672.51
717.52
827.42
growth rate 1.0% 123.2% -8.9% -11.9% 18.3% 4.8% 1.5% 6.7% 15.3%
R&D 39.40
49.20
104.11
162.16
199.75
192.82
184.79
178.53
202.28
268.41
growth rate 24.9% 45.5% 55.8% 23.2% -3.5% -4.2% -3.4% 13.3% 32.7%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 7.28
2.61
15.00
2.74
8.40
growth rate -64.1% 474.7% -81.7% 206.2%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 586.56
592.13
531.72
553.04
503.50
growth rate 1.0% -10.2% 4.0% -9.0%
Acct.Payable 121.62
126.71
73.17
80.59
90.70
growth rate 4.2% -42.3% 10.1% 12.6%
Cur.Assets 855.66
843.74
858.97
834.33
804.10
growth rate -1.4% 1.8% -2.9% -3.6%
Total Assets 4,353.68
4,518.08
3,181.48
3,242.41
3,235.50
growth rate 3.8% -29.6% 1.9% -0.2%
Cash 135.85
111.78
174.24
137.17
138.90
growth rate -17.7% 55.9% -21.3% 1.3%
Inventory
growth rate
Cur.Liabilities 907.17
894.37
797.73
799.62
879.80
growth rate -1.4% -10.8% 0.2% 10.0%
Liabilities 2,756.22
2,933.42
1,601.06
1,786.29
1,919.30
growth rate 6.4% -45.4% 11.6% 7.5%
LT Debt 1,607.68
1,790.52
647.54
766.24
822.70
growth rate 11.4% -63.8% 18.3% 7.4%
Equity 1,112.42
1,087.48
1,551.11
1,456.12
1,316.20
growth rate -2.2% 42.6% -6.1% -9.6%
Common Shares 2.71
2.71
2.71
2.72
1,316.20
growth rate 0.0% 0.0% 0.4% 48,307.5%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 8.01
10.06
9.40
4.85
4.60
growth rate 25.5% -6.5% -48.4% -5.1%
Cash Dividends
growth rate
Cash From OA 8.23
15.01
-13.60
5.82
-7.70
growth rate 82.4% -100.0% 100.0% -100.0%
Sale Purchase of Stock
growth rate
FCF 0.22
4.96
-23.00
0.97
-12.30
growth rate 2,143.0% -100.0% 100.0% -100.0%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 525.58
522.28
442.30
432.05
444.50
growth rate -0.6% -15.3% -2.3% 2.9%
Op.Income 7.28
2.61
15.00
2.74
8.40
growth rate -64.1% 474.7% -81.7% 206.2%
IBT 78.64
-27.64
-40.00
-6.05
-150.40
growth rate -100.0% 0.0% 0.0% 0.0%
Net Income 64.82
-35.99
374.70
-7.55
-149.90
growth rate -100.0% 100.0% -100.0% 0.0%
EPS
growth rate
Gross Profit 245.34
252.93
215.00
202.32
213.10
growth rate 3.1% -15.0% -5.9% 5.3%
R&D 80.34
69.75
66.10
64.31
63.40
growth rate -13.2% -5.2% -2.7% -1.4%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (21.57)

YOY Growth Grade:

F (12.79)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 4.79 4.62 13.21
EPS / Growth 19.3% 2.07 18.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 10.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.7% 16.0% 16.0%
Future PE 4.79 16.66 16.66
Future EPS 5.70 9.11 9.11
Value Price
MOS %
6.75
-29.3%
37.50
293.1%
37.50
293.1%
MOS Price 3.37 18.75 18.75
IRT 3.62 3.30 3.30

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.